CIQF3215-1 Farmacología de Sistemas I

Formulario Sesión de Consultas 2 10 NovYesterday at 20:052025-11-10 20:05:10

Ignacio Gutiérrez Vega
Analgesia Central 2025.pdf 10 NovYesterday at 10:112025-11-10 10:11:10

Mario Rivera M.
Prueba A1 6 NovThursday 6, November at 17:212025-11-06 17:21:06

Mario Rivera M.
Caso clínico 2.pdf 30 OctOctober 30 at 14:022025-10-30 14:02:30

Joaquin Alfaro M.
Seminario 6 Caso clínico 1_20251030_135410_0000.pdf 30 OctOctober 30 at 13:552025-10-30 13:55:30

Marthina Williamson R.
grupo 32 caso 6.pdf 30 OctOctober 30 at 13:522025-10-30 13:52:30

Gabriela Inzunza B.
Caso clínico 5 sección 5 grupo 1 30 OctOctober 30 at 13:512025-10-30 13:51:30

Mariapatricia Suarez T.
Programa de Farmacologia de Sistemas I 2025 V3.docx 29 OctOctober 29 at 17:432025-10-29 17:43:29

Mario Rivera M.
Seminario IV 27 OctOctober 27 at 18:442025-10-27 18:44:27

Ignacio Gutiérrez Vega
Revisión Controles de Seminario I, II y III 27 OctOctober 27 at 16:262025-10-27 16:26:27

Ignacio Gutiérrez Vega
Drogas de Abuso 2025.pdf 27 OctOctober 27 at 13:372025-10-27 13:37:27

Mario Rivera M.
Casos Clínicos Seminario 6.pdf 23 OctOctober 23 at 19:112025-10-23 19:11:23

Ignacio Gutiérrez Vega
Caso clínico 2 Sección 5 23 OctOctober 23 at 14:092025-10-23 14:09:23

Ignacio González Fonseca
seminario 5_20251023_135813_0000.pdf 23 OctOctober 23 at 14:032025-10-23 14:03:23

Marthina Williamson R.
CC23 23 OctOctober 23 at 13:592025-10-23 13:59:23

Constanza Lay
Caso clínico 5_Seccion 5_Grupo 2 23 OctOctober 23 at 13:412025-10-23 13:41:23

Marianela Arias G.
caso clínico 3 sección 5.pdf 23 OctOctober 23 at 13:362025-10-23 13:36:23

Sofía Fuentes M.
Caso clínico 1 Seminario 5 23 OctOctober 23 at 13:342025-10-23 13:34:23

Joaquin Alfaro M.
CASO CLÍNICO 4 S51 23 OctOctober 23 at 13:322025-10-23 13:32:23

Jearlenys Cumana A.
Caso 5 Flunitrazepam Grupo 3-2 23 OctOctober 23 at 13:282025-10-23 13:28:23

Gabriela Inzunza B.
Antiparkinsonianos 2025.pdf 20 OctOctober 20 at 13:532025-10-20 13:53:20

Mario Rivera M.
Anticonvulsivantes 2025.pdf 20 OctOctober 20 at 13:512025-10-20 13:51:20

Mario Rivera M.
Casos Clínicos Seminario 5 v2.pdf 19 OctOctober 19 at 13:472025-10-19 13:47:19

Ignacio Gutiérrez Vega
Distribución Salas Prueba A1 15 OctOctober 15 at 18:592025-10-15 18:59:15

Ignacio Gutiérrez Vega
Distribución A1 15 OctOctober 15 at 18:422025-10-15 18:42:15

Ignacio Gutiérrez Vega

U-Cursos ::

CIQF3215-1 Farmacología de Sistemas I 2025, Segundo Semestre

Farmacología de Sistemas I

CIQF3215-1 - Segundo Semestre 2025

Historial

Formulario Sesión de Consultas 2 10 NovYesterday at 20:052025-11-10 20:05:10

Ignacio Gutiérrez Vega

Analgesia Central 2025.pdf 10 NovYesterday at 10:112025-11-10 10:11:10

Mario Rivera M.

Prueba A1 6 NovThursday 6, November at 17:212025-11-06 17:21:06

Mario Rivera M.

Caso clínico 2.pdf 30 OctOctober 30 at 14:022025-10-30 14:02:30

Joaquin Alfaro M.

Seminario 6 Caso clínico 1_20251030_135410_0000.pdf 30 OctOctober 30 at 13:552025-10-30 13:55:30

Marthina Williamson R.

grupo 32 caso 6.pdf 30 OctOctober 30 at 13:522025-10-30 13:52:30

Gabriela Inzunza B.

Caso clínico 5 sección 5 grupo 1 30 OctOctober 30 at 13:512025-10-30 13:51:30

Mariapatricia Suarez T.

Programa de Farmacologia de Sistemas I 2025 V3.docx 29 OctOctober 29 at 17:432025-10-29 17:43:29

Mario Rivera M.

Seminario IV 27 OctOctober 27 at 18:442025-10-27 18:44:27

Ignacio Gutiérrez Vega

Revisión Controles de Seminario I, II y III 27 OctOctober 27 at 16:262025-10-27 16:26:27

Ignacio Gutiérrez Vega

Drogas de Abuso 2025.pdf 27 OctOctober 27 at 13:372025-10-27 13:37:27

Mario Rivera M.

Casos Clínicos Seminario 6.pdf 23 OctOctober 23 at 19:112025-10-23 19:11:23

Ignacio Gutiérrez Vega

Caso clínico 2 Sección 5 23 OctOctober 23 at 14:092025-10-23 14:09:23

Ignacio González Fonseca

seminario 5_20251023_135813_0000.pdf 23 OctOctober 23 at 14:032025-10-23 14:03:23

Marthina Williamson R.

CC23 23 OctOctober 23 at 13:592025-10-23 13:59:23

Constanza Lay

Caso clínico 5_Seccion 5_Grupo 2 23 OctOctober 23 at 13:412025-10-23 13:41:23

Marianela Arias G.

caso clínico 3 sección 5.pdf 23 OctOctober 23 at 13:362025-10-23 13:36:23

Sofía Fuentes M.

Caso clínico 1 Seminario 5 23 OctOctober 23 at 13:342025-10-23 13:34:23

Joaquin Alfaro M.

CASO CLÍNICO 4 S51 23 OctOctober 23 at 13:322025-10-23 13:32:23

Jearlenys Cumana A.

Caso 5 Flunitrazepam Grupo 3-2 23 OctOctober 23 at 13:282025-10-23 13:28:23

Gabriela Inzunza B.

Antiparkinsonianos 2025.pdf 20 OctOctober 20 at 13:532025-10-20 13:53:20

Mario Rivera M.

Anticonvulsivantes 2025.pdf 20 OctOctober 20 at 13:512025-10-20 13:51:20

Mario Rivera M.

Casos Clínicos Seminario 5 v2.pdf 19 OctOctober 19 at 13:472025-10-19 13:47:19

Ignacio Gutiérrez Vega

Distribución Salas Prueba A1 15 OctOctober 15 at 18:592025-10-15 18:59:15

Ignacio Gutiérrez Vega

Distribución A1 15 OctOctober 15 at 18:422025-10-15 18:42:15

Ignacio Gutiérrez Vega